Company News

Chr Hansen and Novozymes in Largest Ever Danish Merger

The merger of Novozymes and Chr. Hansen Holding, set for Q4 in 2023, will reportedly be the largest ever Danish merger.

Bioscience supplier Chr. Hansen will join with Novozymes, the world’s largest provider of microbial technologies and enzymes, to “create a strong biosolutions group with a broad biological toolbox and a diversified portfolio across markets”.

Novo Holdings, the largest shareholder in both companies, states that the transaction will create a global leader in biosolutions that would capitalize on attractive growth opportunities while serving societal needs.

The combined group will benefit from an expanded global presence and shared ambition to provide answers to the biggest challenges facing society. According to the press release, the newly formed group will “be equipped to stand stronger in addressing global challenges including enabling healthier lives, transforming food systems, and accelerating towards a climate neutral society.”

Bookmark
See all bookmarks

Share